Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-25 @ 7:52 PM
Study NCT ID:
NCT02147535
Status:
COMPLETED
Last Update Posted:
2014-10-13
First Post:
2014-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Impact of CES1 Genotype on Metabolism of Methylphenidate
Sponsor:
Bispebjerg Hospital
Organization:
Study Overview
Official Title:
Impact of CES1 Genotype on Metabolism of Methylphenidate
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether differences in the gene coding for the liver enzyme carboxylesterase 1 (CES1) means differences in the metabolism of methylphenidate, a CES1 dependent drug.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: